Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 09, 2006. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons under the GlaxoSmithKline Performance Share Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share plan transactions.
Specific transaction details include:
- Transaction Date: November 08, 2006
- Share Price: GBP 14.34 per Ordinary Share; $53.80 per Ordinary Share ADR
- Event: Notional re-investment of dividends paid on October 05, 2006
Material Changes
The filing reports an increase in notional interests in Ordinary Shares and ADRs for various executives. This is a routine administrative update regarding the Performance Share Plan and does not represent a material change in the company's operational or financial status compared to prior periods.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three-year measurement period.
Investor Verification Points
- Verify the vesting schedule and conditions for the Performance Share Plan to understand future payout obligations.
- Confirm the total number of shares and ADRs held by the listed executives post-transaction.
- Review the dividend payment date of October 05, 2006, to ensure alignment with the re-investment calculation.